153 related articles for article (PubMed ID: 2785592)
61. [Biochemical markers of bone formation activity in children with neoplasms].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas P; Siedlecka E; Wiśniewska M; Wołczyński S
Wiad Lek; 2005; 58(1-2):29-35. PubMed ID: 15991550
[TBL] [Abstract][Full Text] [Related]
62. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.
de Schepper J; Hachimi-Idrissi S; Louis O; Maurus R; Otten J
Arch Dis Child; 1994 Oct; 71(4):346-8. PubMed ID: 7979531
[TBL] [Abstract][Full Text] [Related]
63. Optimal dietary calcium intake in primary hyperparathyroidism.
Locker FG; Silverberg SJ; Bilezikian JP
Am J Med; 1997 Jun; 102(6):543-50. PubMed ID: 9217669
[TBL] [Abstract][Full Text] [Related]
64. The laboratory evaluation of osteopenia.
Orwoll ES; Belsey RE
Clin Lab Med; 1984 Dec; 4(4):763-74. PubMed ID: 6096078
[TBL] [Abstract][Full Text] [Related]
65. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
[TBL] [Abstract][Full Text] [Related]
66. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
67. Osteocalcin is independently associated with body mass index in adolescent girls.
Dubnov-Raz G; Ish-Shalom S; Chodick G; Rozen GS; Giladi A; Constantini NW
Pediatr Obes; 2012 Aug; 7(4):313-8. PubMed ID: 22577088
[TBL] [Abstract][Full Text] [Related]
68. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
69. Bone mineral and related biochemical variables in patients with Kock ileal reservoir or Bricker conduit for urinary diversion.
Campanello A; Herlitz H; Lindstedt G; Mellström D; Wilske J; Akerland S; Jonsson O
J Urol; 1996 Apr; 155(4):1209-13. PubMed ID: 8632532
[TBL] [Abstract][Full Text] [Related]
70. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
[TBL] [Abstract][Full Text] [Related]
71. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
72. Osteocalcin and bone mineral content in rheumatoid arthritis.
Peretz A; Praet JP; Rozenberg S; Bosson D; Famaey JP; Bourdoux P
Clin Rheumatol; 1989 Mar; 8(1):42-8. PubMed ID: 2787225
[TBL] [Abstract][Full Text] [Related]
73. Bone mineralization and calciotropic hormones in children with hyperthyroidism. Effects of methimazole therapy.
Saggese G; Bertelloni S; Baroncelli GI
J Endocrinol Invest; 1990; 13(7):587-92. PubMed ID: 2229931
[TBL] [Abstract][Full Text] [Related]
74. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism.
Dobnig H; Kainer F; Stepan V; Winter R; Lipp R; Schaffer M; Kahr A; Nocnik S; Patterer G; Leb G
J Clin Endocrinol Metab; 1995 Dec; 80(12):3699-707. PubMed ID: 8530622
[TBL] [Abstract][Full Text] [Related]
75. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.
Glajchen N; Epstein S; Ismail F; Thomas S; Fallon M; Chakrabarti S
Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194
[TBL] [Abstract][Full Text] [Related]
76. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
Chan JC; Kodroff MB; Landwehr DM
Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
[TBL] [Abstract][Full Text] [Related]
77. Hypomagnesemia and the parathyroid hormone-vitamin D endocrine system in children with insulin-dependent diabetes mellitus: effects of magnesium administration.
Saggese G; Federico G; Bertelloni S; Baroncelli GI; Calisti L
J Pediatr; 1991 Feb; 118(2):220-5. PubMed ID: 1993948
[TBL] [Abstract][Full Text] [Related]
78. Bone mineral homeostasis, bone growth, and mineralisation during years of pubertal growth: a unifying concept.
Krabbe S; Transbøl I; Christiansen C
Arch Dis Child; 1982 May; 57(5):359-63. PubMed ID: 7092291
[TBL] [Abstract][Full Text] [Related]
79. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.
Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M
Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447
[TBL] [Abstract][Full Text] [Related]
80. Calcium homeostasis and mineralization in puberty.
Krabbe S
Dan Med Bull; 1989 Apr; 36(2):113-24. PubMed ID: 2651027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
